C07K 14/4706
Guanosine triphosphatase activating protein, gap
Official title: {Guanosine triphosphatase activating protein, GAP}
C07K14/4706 (Guanosine triphosphatase activating protein, gap) appears on 33 US grants and 40 published applications in this corpus.
Search patents in C07K- Granted patents
- 33
- Published applications
- 40
- Assignees
- 46
- Inventors
- 117
- Latest grant
- 5 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 3 | 0 |
| 1999 | 2 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 3 | 5 |
| 2003 | 0 | 3 |
| 2004 | 1 | 2 |
| 2005 | 0 | 2 |
| 2006 | 1 | 2 |
| 2007 | 1 | 1 |
| 2008 | 1 | 2 |
| 2009 | 0 | 4 |
| 2010 | 1 | 0 |
| 2011 | 1 | 3 |
| 2012 | 2 | 2 |
| 2013 | 0 | 1 |
| 2014 | 2 | 1 |
| 2015 | 1 | 1 |
| 2016 | 1 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 1 |
| 2021 | 0 | 0 |
| 2022 | 1 | 1 |
| 2023 | 1 | 3 |
| 2024 | 0 | 3 |
| 2025 | 0 | 0 |
| 2026 | 2 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Probe and method for detecting membrane-associated molecules in living cells5 May 2026US 12,618,828 B2
- Aav vectors encoding NF1 and uses thereof13 Jan 2026US 12,522,845 B2University of Massachusetts
- RP2 and RPGR vectors for treating X-linked retinitis pigmentosa4 Apr 2023US 11,617,801 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- AAV vectors encoding NF1 and uses thereof2 Aug 2022US 11,401,531 B2University of Massachusetts
- RP2 and RPGR vectors for treating X-linked retinitis pigmentosa12 May 2020US 10,646,588 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Probe and Method for Detecting Membrane-Associated Molecules in Living Cells17 Sep 2026US 2026/0276629 A1
- Marker for lymphocytic adenohypophysitis and related diseases, and use of the marker19 Sep 2024US 2024/0310374 A1Fujita Academy
- Gene therapy for tuberous sclerosis8 Aug 2024US 2024/0261439 A1BridgeBio Gene Therapy Research, Inc.
- G protein peptidomimetics14 Mar 2024US 2024/0083958 A1Vrije Universiteit Brussel
- Probe and Method for Detecting Membrane-Associated Molecules in Living Cells22 Jun 2023US 2023/0194503 A1Ustav Organicke Chemie A Biochemie Av Cr, V. V. I.
Most cited
By later US patents
- Method for assaying for a substance that affects a SH2-phosphorylated ligand regulatory system61US 5,352,660 AMount Sinai Hospital · 1994
- Compositions for detecting ras gene proteins and cancer therapeutics50US 5,104,975 ACetus Corporation · 1992
- Compositions for detecting ras gene proteins and cancer therapeutics47US 5,234,839 ACetus Oncology Corporation · 1993
- Peptides capable of binding to the GAP protein SH3 domain, nucleotide sequences coding therefor, and preparation and use thereof21US 5,886,150 ARhone-Poulenc Rorer S.A. · 1999
- Peptide synthesis and purification by fusion to penI protein or precipitation effective portion thereof10US 5,888,775 ADade International Inc. · 1999